Young Investigator Prizes in Basic and Clinical Science

Eligibility 

The Prize Laureate must be an independent investigator conducting exemplary research in basic or clinical science in the field of celiac disease. The Prize Laureate must have an MD, PhD and/or equivalent degree(s) and hold a faculty position for less than ten years. 

The Prize will be awarded based on actual research contributions, and not for the establishment or development of a research institution or research infrastructure, and awarded solely on the significance of their work to an area of research in celiac disease. To avoid the appearance of conflict of interest, employees of for-profit pharmaceutical or biotechnology companies will not be eligible. Prior Prize Laureates are not eligible for nomination, but prior Nominees who were not selected in previous award cycles may be nominated in subsequent award cycles with no limit. Previous recipients of the Warren Prize for Excellence in Celiac Disease Research or the Maki Celiac Disease Tampere Prize are not eligible for nomination. English is the official language for the Prize administration, including the nomination process, deliberations, and associated materials as described herein.  

Nominations 

Nominations for the Prize Laureate will only be made by members of the Selection Jury. The Prize is not open to application, although Jurors may choose Nominees recommended by the celiac disease community at large through an open call for Letters of Recommendation for Nominations. Jurors are asked not to discuss or confer regarding potential Nominees or actual nominations with other Jurors prior to or outside of official deliberations. A Nominee may be nominated by multiple Jurors, and Jurors will not be asked to make an alternate nomination in the case of multiple nominations from any other Juror(s). The Juror may inform Nominees that they have been nominated, but the Celiac Disease Foundation will coordinate directly with all Nominees on all aspects of the Nomination Process.  

The Celiac Disease Foundation will make an open call for Letters of Recommendation for Nominations of no more than 500 words to give the community at-large an opportunity to suggest Nominees for the Prize. Only those Letters submitted during the timeframe specified will be considered. The Celiac Disease Foundation will compile all Letters of Recommendation and distribute them to the Selection Jury.  Any person writing a Letter of Recommendation for Nominations is prohibited from making unsolicited contact with Jurors. Violating this rule will result in the withdrawal of the Letter of Recommendation for Nomination. The Celiac Disease Foundation will compile a Nomination Dossier for each Nominee that will be circulated to the Jurors for review prior to deliberations, consisting of:  

1. Nomination Statement of no more than 500 words, written by the Juror making the nomination and addressing the selection criteria  
2. Nominee’s curriculum vitae with career and publication highlights 

Selection Process 

A quorum of five Jurors must be present for the entirety of deliberations. Jurors may not be presented as Nominees during their service on the Selection Jury. The deliberations will be confidential and closed. Only Selection Jury members and representatives of the Celiac Disease Foundation may be present during the deliberations. In addition, names of all unselected Nominees shall remain confidential.  

Announcement of Prize Laureate 

Coordination of the announcement of the Prize Laureate will be the responsibility solely of the Celiac Disease Foundation. The Prize will be officially conferred upon the Prize Laureate at a DDW reception, or by similar ceremony. The Prize Laureate will be provided with two round-trip coach airfares and hotel accommodations for up to two nights and other travel-related expenses.  

The Prize Laureate will present a lecture at the DDW reception, or similar ceremony at the time of presentation of the Prize. 

2023 nominations are now closed. Nominations will reopen January 2, 2024.